Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference

San Francisco – April 1, 2019 – BlackThorn Therapeutics, a neurobehavioral health company leveraging its proprietary computational psychiatr...

BOSTON--(BUSINESS WIRE)--Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, and Anheuser-Busch, the country’s leading brewer, have announced a partnership focused on sustainable rice production. Indigo has committed to delivering 2.2 million bushels o...

Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR editing. Beam’s promise of CRISPR-based therapeutics that swap out specific bases or “letters” in the genome—something the current generation of CRISPR-based drugs can’t...

Late last month, Gossamer Bio filed to raise up to $230 million in a fixed-price IPO so it could go public despite the partial shutdown of the U.S. government. Now that the government has reopened, the San Diego biotech has returned to its original plan, pricing its traditional IPO at $276 million. 

The Sa...

• Indigo Transport is a full-service digital logistics platform designed to connect shippers and carriers for the efficient haul of agricultural products

• Indigo Transport is integrated within Indigo Marketplace™ to enable access to a range of buyers, including those outside of a grower’s immediate...

• BTRX-335140 Poised to Enter Phase 2 Efficacy Studies and BTRX-323511 to Enter IND-enabling Studies

• Company Increasing Investment in Computational Psychiatry (CompPsych) Platform for Targeted CNS Therapeutics and Deprioritizing BTRX-246040 to Focus on Proprietary Programs

• BlackThorn Participa...

• Indigo has acquired TellusLabs, a leader in the use of satellite technology and artificial intelligence whose mission is to build a living map of the world's food supply.

• TellusLabs' agricultural intelligence technology will integrate with Indigo's deep record of on-farm data, culminating in a pl...

• Merger with OvaScience Closed 

• Shares of Combined Company to Commence Trading on the Nasdaq Capital Market

• Under New Symbol “MLND” on Monday, December 10th, 2018 

• Proceeds of $85.4 Million to Fund Orphan Endocrine Pipeline 

• Pivotal Phase 2b/3 Trial for Prader-Willi Syndrome Initiat...

• Novel investigational RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection

• Subject dosing commenced

SAN FRANCISCO, Calif. and CAMBRIDGE, Mass. – November 26, 2018 - Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation...

SAN DIEGO, Oct. 16, 2018 /PRNewswire/ -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced it has entered into a clinical collaboration agreement with Merck (known as MSD outside the United States and Canada), t...